Scandinavian ChemoTech has passed the final revision of IQwave and increases its chances of CE marking before the deadline
ChemoTech can now sum up great progress after completing the three-day long and intensive revision of the Company's quality system and review of its critical processes required for CE marking of medical devices in the EU.After a comprehensive revision (on-site - via video) of the Company's quality system and all processes prior to the CE marking, which was carried out last week, only a final review of a few documents submitted on 12 May now remains. “Even though we have not secured our CE marking yet, we are proud to have passed the physical revision, which is the most critical part of